July 29 (Reuters) - Novartis AG:
* Vaccines begins shipment of seasonal influenza vaccine Fluvirin(R) to U.S.
market to help protect ahead of 2010-2011 flu season
* Says plans to supply the U.S. market with approximately 40 million doses of
Fluvirin influenza virus vaccine
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Vaccines begins shipment of seasonal influenza vaccine Fluvirin(R) to U.S.
market to help protect ahead of 2010-2011 flu season
* Says plans to supply the U.S. market with approximately 40 million doses of
Fluvirin influenza virus vaccine
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
